Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. [electronic resource]
Producer: 20050114Description: 331-9 p. digitalISSN:- 0012-186X
- Animals
- Apoptosis
- Blood Glucose -- drug effects
- Body Weight -- drug effects
- Caspase 3
- Caspase Inhibitors
- Caspases -- metabolism
- Cell Line, Tumor
- Choline O-Acetyltransferase -- metabolism
- Diabetes Mellitus, Experimental -- complications
- Diabetic Neuropathies -- etiology
- Drug Synergism
- Enzyme Inhibitors -- pharmacology
- Esophagogastric Junction -- chemistry
- Ganglia -- chemistry
- Gene Expression -- drug effects
- Glucose -- pharmacology
- Glycation End Products, Advanced -- blood
- Immunohistochemistry
- Insulin -- pharmacology
- Male
- Nitrergic Neurons -- drug effects
- Nitric Oxide -- physiology
- Nitric Oxide Synthase -- antagonists & inhibitors
- Nitric Oxide Synthase Type I
- Penis -- chemistry
- Rats
- Rats, Wistar
- Reactive Oxygen Species -- metabolism
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic -- metabolism
- Serum Albumin -- chemistry
- Tretinoin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.